Isis Innovation is a wholly owned subsidiary of the University of Oxford, founded to exploit know-how arising out of research at one of the World's premier research institutions More
CryoLife Inc (NYSE-CRY) formed AuraZyme(TM), a wholly owned subsidiary, to foster development of its propietary A-Z-CINN(tm) Linker for creating better targeted drug delivery systems. More